Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trastuzumab + Chemotherapy vs Chemotherapy Alone as Adjuvant Therapy for Stage IB-II HER2+ Gastric Cancer
NCT07788196Phase 2Recruiting
- Sponsor
- Xijing Hospital
- Start
- Jul 2026
- Primary completion
- Dec 2030
- Countries
- 1
01
Overview
A Phase 2 trial of trastuzumab in gastric cancer (GC), gastroesophageal junction cancer, sponsored by Xijing Hospital. Started Jul 2026; status: recruiting.
02
Drugs
03
Conditions
gastric cancer (GC)gastroesophageal junction cancer
Beyond the preview
Go deeper on NCT07788196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07788196.